| Literature DB >> 30781746 |
Ciosek Żaneta1,2, Kosik-Bogacka Danuta3, Łanocha-Arendarczyk Natalia4, Kot Karolina5, Karaczun Maciej6, Ziętek Paweł7, Kupnicka Patrycja8, Szylińska Aleksandra9, Bosiacki Mateusz10, Rotter Iwona11.
Abstract
The aim of the study was to assess phosphorus (P) concentration in structures of the knee joint-including the tibial spongy bone, articular cartilage, meniscus, anterior cruciate ligament, and infrapatellar fat pad (Hoffa's fat pad)-of patients following knee joint replacement. The study also aimed to assess the influence of selected biological and environmental factors on P concentration in studied parts of the knee joint. Phosphorus concentration was determined using inductively coupled plasma-atomic emission spectrometry (ICP-AES). Statistically significant differences in P concentration were found between different elements of the knee joint. The highest P concentration was measured in the spongy bone (72,746.68 mg kg-1 dw) and the lowest in the Hoffa's fat pad (1203.19 mg kg-1 dw). P levels were unaffected by gender, age, BMI, place of residence, smoking, or alcohol consumption. Data on P concentration in the osteoarticular elements of the knee may be useful in the interpretation and evaluation of biochemical, morphological, and mechanical changes occurring in the body.Entities:
Keywords: Hoffa’s fat pad; endoprosthesia; phosphorus
Mesh:
Substances:
Year: 2019 PMID: 30781746 PMCID: PMC6406424 DOI: 10.3390/ijerph16040525
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Assessment relationship of P concentration in the majority of knee joint elements
| Variables |
|
| |
|---|---|---|---|
| SB | JC | 0.025 | 0.867 |
| MM | −0.143 | 0.343 | |
| ACL | 0.012 | 0.939 | |
| HFB | 0.293 | 0.048 | |
| JC | SB | 0.025 | 0.867 |
| MM | −0.386 | 0.008 | |
| ACL | −0.017 | 0.911 | |
| HFB | 0.026 | 0.866 | |
| MM | SB | −0.143 | 0.343 |
| JC | −0.386 | 0.008 | |
| ACL | 0.398 | 0.006 | |
| HFB | 0.038 | 0.801 | |
| ACL | SB | 0.012 | 0.939 |
| JC | −0.017 | 0.911 | |
| MM | 0.398 | 0.006 | |
| HFB | 0.050 | 0.740 | |
| HFB | SB | 0.293 | 0.048 |
| JC | 0.026 | 0.866 | |
| MM | 0.038 | 0.801 | |
| ACL | 0.050 | 0.740 | |
Abbreviations: SB, spongy bone; JC, articular cartilage; MM, meniscus; ACL, anterior cruciate ligament; HFB, infrapatellar fat pad, R, corrleation, p, statistical significance; Notes: The concentration P of elements is expressed in mg kg−1 of dry weight.
Effect of biological factors on phosphorus concentration in knee joint elements (mg kg−1 dw) taken from patients from northwestern Poland.
| Type of Sample | AM ± SD | Med | Min–Max |
|---|---|---|---|
| Patients ( | |||
| SB | 72,746.68 ± 12,061.77 | 72,471.09 | 51,266.70–98,448.56 |
| JC | 71,554.92 ± 16,157.19 | 70,799.11 | 39,067.57–112,679.0 |
| MM | 4830.99 ± 7115.91 | 2476.49 | 472.85–33,893.78 |
| ACL | 10,008.35 ± 16,551.30 | 4284.61 | 562.71–90,935.23 |
| HFB | 1203.19 ± 1557.07 | 857.66 | 235.11–10,325.85 |
| Gender | |||
| Female ( | |||
| SB | 73,430.27 ± 11,608.62 | 72,845.40 | 52,338.90–97,343.44 |
| JC | 69,172.20 ± 15,896.23 | 69,187.37 | 39,067.57–112,679.0 |
| MM | 4650.83 ± 6297.67 | 2493.17 | 472.85–31,308.95 |
| ACL | 10,394.87 ± 16,873.36 | 4284.62 | 562.71–90,935.23 |
| HFB | 1049.90 ± 806.95 | 876.91 | 235.11–3470.86 |
| Male ( | |||
| SB | 70,809.83 ± 13,614.49 | 71,663.26 | 51,266.70–98,448.56 |
| JC | 78,305.96 ± 15,576.04 | 80,738.77 | 54,499.17–99,729.98 |
| MM | 5341.46 ± 9369.19 | 2358.73 | 590.48–33,893.78 |
| ACL | 8913.19 ± 16,272.24 | 5175.06 | 936.93–59,697.62 |
| HFB | 1637.52 ± 2772.42 | 830.82 | 252.00–10,325.85 |
| Age | |||
| HS 1 ( | |||
| SB | 73,530.83 ± 9124.11 | 73,880.72 | 936.3–59,697.62 |
| JC | 72,094.25 ± 25,533.08 | 70,988.14 | 39,067.57–112,679.0 |
| MM | 2938.96 ± 2466.80 | 2469.92 | 235.11–3470.86 |
| ACL | 19,513.81 ± 52,073.33 | 17,229.73 | 53,470.49–95,946.84 |
| HFB | 749.10 ± 510.90 | 698.35 | 485.49–16,776.24 |
| HS 2 ( | |||
| SB | 73,882.88 ± 13,065.77 | 73,171.86 | 562.71–90,935.23 |
| JC | 72,135.13 ± 15,197.24 | 71,458.87 | 43,644.2–102,399.15 |
| MM | 6313.01 ± 9885.79 | 2426.79 | 352.78–10,325.85 |
| ACL | 9659.42 ± 19,337.85 | 5400.29 | 51,266.70–98,448.56 |
| HFB | 1602.49 ± 2180.62 | 1063.48 | 472.85–33,893.78 |
| BMI | |||
| Normal weight ( | |||
| SB | 75,990.78 ± 20,426.03 | 75,990.78 | 61,547.40–90,434.17 |
| JC | 93,111.09 ± 13,135.23 | 93,111.09 | 83,823.08–102,399.1 |
| MM | 1478.90 ± 1404.90 | 1478.90 | 485.48–2472.31 |
| ACL | 1672.51 ± 915.61 | 1672.51 | 1025.07–2319.94 |
| HFB | 1042.48 ± 348.32 | 1042.48 | 796.18–1288.78 |
| Overweight ( | |||
| SB | 74,736.08 ± 12,894.86 | 73,917.05 | 52,338.90–98,448.56 |
| JC | 71,281.61 ± 15,284.51 | 71,403.87 | 43,644.19–99,729.98 |
| MM | 4696.37 ± 7052.22 | 2238.27 | 590.48–31,308.95 |
| ACL | 10,389.42 ± 20,358.44 | 4127.79 | 936.93–90,935.23 |
| HFB | 1011.19 ± 708.18 | 886.42 | 252.00–3227.54 |
| Class I obesity ( | |||
| SB | 69,822.70 ± 12,903.61 | 70,315.04 | 51,266.70–95,946.84 |
| JC | 69,961.24 ± 19,109.26 | 75,310.84 | 39,067.57–112,679.0 |
| MM | 6869.02 ± 8648.24 | 4445.61 | 472.85–33,893.78 |
| ACL | 11,414.03 ± 15,049.27 | 6204.76 | 995.34–59,697.62 |
| HFB | 1426.47 ± 2390.02 | 759.58 | 235.11–10,325.85 |
| Class II obesity ( | |||
| SB | 71,611.38 ± 3622.87 | 72,220.95 | 65,086.30–75,400.92 |
| JC | 70,985.20 ± 10,128.26 | 67,765.47 | 58,801.38–87,184.72 |
| MM | 1675.74 ± 1351.80 | 1321.33 | 523.69–4227.50 |
| ACL | 4523.12 ± 1981.39 | 4284.62 | 2013.50–7345.53 |
| HFB | 1397.59 ± 1112.22 | 1020.02 | 434.26–3470.86 |
| Class III obesity ( | |||
| SB | 78,862.89 ± 9102.20 | 78,862.89 | 72,426.66–85,299.12 |
| JC | 67,850.65 ± 3314.50 | 67,850.65 | 65,506.94–70,194.35 |
| MM | 1604.58 ± 1286.16 | 1604.58 | 695.13–2514.04 |
| ACL | 19,231.35 ± 26,401.45 | 19,231.35 | 562.71–37,900.00 |
| HFB | 706.77 ± 229.39 | 706.77 | 544.57–868.97 |
Abbreviations: SB, spongy bone; JC, articular cartilage; MM, meniscus; ACL, anterior cruciate ligament; HFB, infrapatellar fat pad; AM, arithmetic average, SD, standard deviation; Med, median; min–max, range; HS 1, age 55–74 years; HS 2, age 75–89 years; BMI, body mass index; Notes: The concentration of elements is expressed in mg kg−1 of dry weight. Comparison of P concentration according to age, gender, BMI category is not statistical significance.
Effect of environmental factors on phosphorus concentration in knee joint elements (mg kg−1 dw) taken from patients from northwestern Poland.
| Type of Sample | AM±SD | Med | Min–Max |
|---|---|---|---|
| Place of residence | |||
| V ( | |||
| SB | 74,641.95 ± 72,515.52 | 65,086.30 | 61,363.49–88,945.31 |
| JC | 69,368.25 ± 65,506.94 | 64,303.14 | 58,801.38–83,818.32 |
| MM | 3023.14 ± 2514.04 | 2480.67 | 1037.63–4855.88 |
| ACL | 10,604.88 ± 4347.22 | 2652.16 | 1311.04–37,900.00 |
| HFB | 2599.68 ± 868.97 | 326.85 | 252.00–10,325.85 |
| SC ( | |||
| SB | 69,178.90 ± 67,969.33 | 53,621.20 | 52,338.90–98,448.56 |
| JC | 78,701.33 ± 79,139.09 | 57,301.57 | 39,067.57–112,679.0 |
| MM | 7897.08 ± 1895.86 | 862.09 | 472.85–31,308.95 |
| ACL | 7891.70 ± 6301.34 | 2319.94 | 562.71–90,935.23 |
| HFB | 1240.97 ± 1266.00 | 1046.60 | 235.11–3470.86 |
| C ( | |||
| SB | 73,087.54 ± 72,426.66 | 65,490.03 | 51,266.70–87,887.98 |
| JC | 70,642.20 ± 70,194.35 | 61,064.08 | 54,499.17–102,399.1 |
| MM | 4563.64 ± 2381.27 | 836.72 | 590.48–33,893.78 |
| ACL | 10,285.98 ± 4222.01 | 2511.34 | 936.93–22,228.15 |
| HFB | 997.21 ± 770.13 | 423.41 | 886.42–1581.60 |
| Smoking | |||
| Smokers ( | |||
| SB | 66,695.90 ± 9966.86 | 70,315.04 | 53,470.49–80,069.83 |
| JC | 66,318.02 ± 17,913.35 | 65,962.78 | 42,754.52–92,812.09 |
| MM | 4454.42 ± 5681.36 | 3265.22 | 523.68–16,776.24 |
| ACL | 3334.95 ± 2661.05 | 1913.92 | 995.34–7345.53 |
| HFB | 646.54 ± 320.97 | 759.58 | 259.44–1141.50 |
| Non-smokers ( | |||
| SB | 73,832.71 ± 12,192.07 | 72,572.29 | 51,266.70–98,448.56 |
| JC | 72,494.87 ± 15,890.83 | 71,403.87 | 39,067.57–112,679.0 |
| MM | 4898.58 ± 7405.17 | 2472.31 | 472.85–33,893.78 |
| ACL | 11,206.13 ± 17,709.18 | 4347.22 | 562.71–90,935.23 |
| HFB | 1303.10 ± 1669.58 | 886.42 | 235.11–10,325.85 |
| Alcohol consumption | |||
| A ( | |||
| SB | 71,049.86 ± 7679.01 | 71,365.24 | 61,399.11–80,069.83 |
| JC | 71,579.29 ± 21,700.83 | 72,405.42 | 48,694.23–92,812.0 |
| MM | 2689.09 ± 1958.69 | 2317.64 | 968.24–5152.84 |
| ACL | 3537.18 ± 2845.12 | 3465.53 | 995.34–6222.34 |
| HFB | 760.35 ± 340.19 | 792.71 | 314.49–1141.50 |
| NA ( | |||
| SB | 72,908.28 ± 12,452.22 | 72,543.91 | 51,266.70–98,448.56 |
| JC | 71,552.60 ± 15,876.57 | 70,799.11 | 39,067.57–112,679.1 |
| MM | 5034.99 ± 7403.06 | 2476.49 | 472.85–33,893.78 |
| ACL | 10,624.65 ± 17,193.17 | 4284.62 | 562.71–90,935.23 |
| HFB | 1245.36 ± 1622.21 | 876.91 | 235.11–10,325.85 |
Abbreviations: SB, spongy bone; JC, articular cartilage; MM, meniscus; ACL, anterior cruciate ligament; HFB, infrapatellar fat pad; AM, arithmetic average, SD, standard deviation; Med, median; min-max, range; V, patients living in rural areas; SC, people living in cities of up to 100,000 inhabitants; C, people living in cities over 100,000 inhabitants; A, people regularly consuming alcohol; NA, abstainers. Notes: Comparison of P concentration according to place of residence, smoking, alcohol consumption is not statistical significance.